Study of inflammatory markers at the preclinical stage of Huntington’s disease
DOI:
https://doi.org/10.25557/2310-0435.2022.03.61-62Keywords:
NeuroimmunopathologyAbstract
Conference abstract
Downloads
Published
2022-10-13
Issue
Section
Brief reports
How to Cite
Study of inflammatory markers at the preclinical stage of Huntington’s disease. (2022). Patogenez (Pathogenesis), 20(3), 61-62. https://doi.org/10.25557/2310-0435.2022.03.61-62